313 related articles for article (PubMed ID: 30508794)
21. Synthesis and SARs study of novel spiro-oxindoles as potent antiproliferative agents with CDK-2 inhibitory activities.
Al-Jassas RM; Islam MS; Al-Majid AM; Nafie MS; Haukka M; Rahman AFMM; Alayyaf AMA; Barakat A
Arch Pharm (Weinheim); 2023 Aug; 356(8):e2300185. PubMed ID: 37253118
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of novel steroidal spiro-oxindoles as potent antiproliferative agents.
Yu B; Shi XJ; Qi PP; Yu DQ; Liu HM
J Steroid Biochem Mol Biol; 2014 May; 141():121-34. PubMed ID: 24508598
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of new substituted spirooxindoles as potential inhibitors of the MDM2-p53 interaction.
Barakat A; Islam MS; Ghawas HM; Al-Majid AM; El-Senduny FF; Badria FA; Elshaier YAMM; Ghabbour HA
Bioorg Chem; 2019 May; 86():598-608. PubMed ID: 30802707
[TBL] [Abstract][Full Text] [Related]
24. Combined Scaffold Evaluation and Systems-Level Transcriptome-Based Analysis for Accelerated Lead Optimization Reveals Ribosomal Targeting Spirooxindole Cyclopropanes.
Rodriguez KX; Howe EN; Bacher EP; Burnette M; Meloche JL; Meisel J; Schnepp P; Tan X; Chang M; Zartman J; Zhang S; Ashfeld BL
ChemMedChem; 2019 Sep; 14(18):1653-1661. PubMed ID: 31140738
[TBL] [Abstract][Full Text] [Related]
25. Spirooxindole-pyrrolidine heterocyclic hybrids promotes apoptosis through activation of caspase-3.
Kumar RS; Almansour AI; Arumugam N; Mohammad F; Kotresha D; Menéndez JC
Bioorg Med Chem; 2019 Jun; 27(12):2487-2498. PubMed ID: 30853330
[TBL] [Abstract][Full Text] [Related]
26. Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction.
Ding K; Lu Y; Nikolovska-Coleska Z; Wang G; Qiu S; Shangary S; Gao W; Qin D; Stuckey J; Krajewski K; Roller PP; Wang S
J Med Chem; 2006 Jun; 49(12):3432-5. PubMed ID: 16759082
[TBL] [Abstract][Full Text] [Related]
27. Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53-MDM2 Interaction Useful in Targeted Cancer Therapy.
Gupta AK; Bharadwaj M; Kumar A; Mehrotra R
Top Curr Chem (Cham); 2017 Feb; 375(1):3. PubMed ID: 27943171
[TBL] [Abstract][Full Text] [Related]
28. Discovery of novel polycyclic spiro-fused carbocyclicoxindole-based anticancer agents.
Zhang L; Ren W; Wang X; Zhang J; Liu J; Zhao L; Zhang X
Eur J Med Chem; 2017 Jan; 126():1071-1082. PubMed ID: 28027532
[TBL] [Abstract][Full Text] [Related]
29. Facile one-pot synthesis of novel dispirooxindole-pyrrolidine derivatives and their antimicrobial and anticancer activity against A549 human lung adenocarcinoma cancer cell line.
Arun Y; Bhaskar G; Balachandran C; Ignacimuthu S; Perumal PT
Bioorg Med Chem Lett; 2013 Mar; 23(6):1839-45. PubMed ID: 23395665
[TBL] [Abstract][Full Text] [Related]
30. One-pot synthesis of spiro(indoline-3,4'-pyrazolo[3,4-b]pyridine)-5'-carbonitriles as p53-MDM2 interaction inhibitors.
Ibrahim HS; Eldehna WM; Fallacara AL; Ahmed ER; Ghabbour HA; Elaasser MM; Botta M; Abou-Seri SM; Abdel-Aziz HA
Future Med Chem; 2018 Dec; 10(24):2771-2789. PubMed ID: 30526032
[TBL] [Abstract][Full Text] [Related]
31. Exploiting the antiproliferative potential of spiropyrazoline oxindoles in a human ovarian cancer cell line.
Raposo LR; Silva A; Silva D; Roma-Rodrigues C; Espadinha M; Baptista PV; Santos MMM; Fernandes AR
Bioorg Med Chem; 2021 Jan; 30():115880. PubMed ID: 33348171
[TBL] [Abstract][Full Text] [Related]
32. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies.
Senwar KR; Sharma P; Reddy TS; Jeengar MK; Nayak VL; Naidu VG; Kamal A; Shankaraiah N
Eur J Med Chem; 2015 Sep; 102():413-24. PubMed ID: 26301558
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological evaluation of novel antitumor spirotetrahydrothiopyran-oxindole derivatives as potent p53-MDM2 inhibitors.
Ji C; Wang S; Chen S; He S; Jiang Y; Miao Z; Li J; Sheng C
Bioorg Med Chem; 2017 Oct; 25(20):5268-5277. PubMed ID: 28797774
[TBL] [Abstract][Full Text] [Related]
34. Potency and Selectivity Optimization of Tryptophanol-Derived Oxazoloisoindolinones: Novel p53 Activators in Human Colorectal Cancer.
Barcherini V; Almeida J; Lopes EA; Wang M; Magalhães E Silva D; Mori M; Wang S; Saraiva L; Santos MMM
ChemMedChem; 2021 Jan; 16(1):250-258. PubMed ID: 32737944
[TBL] [Abstract][Full Text] [Related]
35. Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity.
Mahmoud HK; Farghaly TA; Abdulwahab HG; Al-Qurashi NT; Shaaban MR
Eur J Med Chem; 2020 Dec; 208():112752. PubMed ID: 32947227
[TBL] [Abstract][Full Text] [Related]
36. Spiro[pyrrolidine-3,3'-oxindoles] and Their Indoline Analogues as New 5-HT6 Receptor Chemotypes.
Kelemen ÁA; Satala G; Bojarski AJ; Keserű GM
Molecules; 2017 Dec; 22(12):. PubMed ID: 29240714
[TBL] [Abstract][Full Text] [Related]
37. A One-Pot Three-Component Synthesis and Investigation of the In Vitro Mechanistic Anticancer Activity of Highly Functionalized Spirooxindole-Pyrrolidine Heterocyclic Hybrids.
Kumar RS; M Al-Thamili D; Almansour AI; Arumugam N; Mohammad F
Molecules; 2020 Nov; 25(23):. PubMed ID: 33261115
[TBL] [Abstract][Full Text] [Related]
38. Combinatorial synthesis of functionalized spirooxindole-pyrrolidine/pyrrolizidine/pyrrolothiazole derivatives via three-component 1,3-dipolar cycloaddition reactions.
Li J; Wang J; Xu Z; Zhu S
ACS Comb Sci; 2014 Sep; 16(9):506-12. PubMed ID: 25033950
[TBL] [Abstract][Full Text] [Related]
39. In vitro targeting of colon cancer cells using spiropyrazoline oxindoles.
Nunes RC; Ribeiro CJA; Monteiro Â; Rodrigues CMP; Amaral JD; Santos MMM
Eur J Med Chem; 2017 Oct; 139():168-179. PubMed ID: 28800455
[TBL] [Abstract][Full Text] [Related]
40. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies.
Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC
Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
